GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » Interest Expense

Notable Labs (Notable Labs) Interest Expense : $ Mil (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Notable Labs Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Notable Labs's interest expense for the six months ended in Dec. 2023 was $ 0.00 Mil. Notable Labs does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in Dec. 2023.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Notable Labs's Operating Income for the six months ended in Dec. 2023 was $ -14.66 Mil. Notable Labs's Interest Expense for the six months ended in Dec. 2023 was $ 0.00 Mil. GuruFocus does not calculate Notable Labs's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Notable Labs Interest Expense Historical Data

The historical data trend for Notable Labs's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Notable Labs Interest Expense Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
Interest Expense
- - -

Notable Labs Semi-Annual Data
Dec21 Dec22 Dec23
Interest Expense - - -

Notable Labs Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Notable Labs  (NAS:NTBL) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Notable Labs's Interest Expense for the six months ended in Dec. 2023 was $0.00 Mil. Its Operating Income for the six months ended in Dec. 2023 was $-14.66 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was $1.53 Mil.

Notable Labs's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

GuruFocus does not calculate Notable Labs's interest coverage with the available data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Notable Labs Ltd has enough cash to cover all of its debt. Its financial situation is stable.

Notable Labs (Notable Labs) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » Interest Expense
Comparable Companies
NLSP ACST AGE CRBP NBIO CLRB AIM PLUR BIXT SNSE OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
320 Hatch Drive, Foster City, CA, USA, 94404
Website
https://notablelabs.com
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic.